Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an)

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) has issued an update. Foremost Clean Energy has closed a bought deal private placement ra...

Foremost Clean Energy Raises C$5.7 Million in Flow-Through Financing for Critical Minerals Exploration

Focus Graphite ( ($TSE:FMS) ) has issued an announcement. Focus Graphite has commissioned WSP Canada to conduct a comprehensive dam break study for...

Focus Graphite Launches WSP-Led Dam Break Study to Advance Lac Knife Permitting

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) has shared an announcement. Foremost Clean Energy Ltd., a North American uranium and lith...

Foremost Clean Energy Raises C$5.5 Million in Flow‑Through Bought Deal to Advance Uranium and Lithium Projects

In a report released on March 13, from DZ BANK AG maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA. The company’s shares closed last...

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG

Focus Graphite ( ($TSE:FMS) ) has issued an update. Focus Graphite has hired Canadian engineering firm Norda-Stelo to select corridors and conduct ...

Focus Graphite Targets Infrastructure Edge at Lac Knife with New Road and Power Study

Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €46.50. Accordin...

Barclays Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA on March 10 and set a price target of €43.0...

Current Quarter	$0.54	Next Quarter	$0.6
Current Year	$2.48	Next Year	$2.62
QoQ Growth	+11.1%	YoY Growth	+5.6%
3Y EPS CAGR	-36.8%	Target Price	$24.48
Consensus	Buy	Upside	+9.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FMS	$22.45	+0.18%	209.87K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FMS	$22.45	+0.2%	209.87K
3
4
5
6

FMS

FMS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel

Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel